Clincosm LogoSign in Get a demo

moderate and severe rheumatoid arthritis

Showing 1 - 2 of 2
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Moderate and Severe RheumatoId Arthritis Trial in Beijing (Placebo plus MTX, RC18 160 mg plus MTX)

Active, not recruiting
  • Moderate and Severe RheumatoId Arthritis
  • Placebo plus MTX
  • RC18 160 mg plus MTX
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jan 9, 2022

Moderate and Severe Rheumatoid Arthritis Trial in Shanghai (Placebo plus MTX, RC18 160 mg plus MTX)

Terminated
  • Moderate and Severe Rheumatoid Arthritis
  • Placebo plus MTX
  • RC18 160 mg plus MTX
  • Shanghai, Shanghai, China
    Renji Hospital Shanghai Jiaotong University School of Medicine
Apr 1, 2019